.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A Cochrane review of randomized trials comparing multifocal and monofocal intraocular lenses found that multifocal IOLs improve unaided near vision and increase the likelihood of spectacle independence. Distance visual acuity was broadly similar between lens strategies. The trade-off was a higher frequency of optical phenomena, particularly glare and halos, with the certainty of evidence varying across outcomes. The review is highly relevant to contemporary presbyopia-correcting cataract practice because the decision is not simply about maximizing an acuity number. Patient selection, expectations, ocular surface status, macular health, contrast sensitivity, and tolerance for night-vision phenomena all influence satisfaction. For surgeons, the evidence supports individualized lens counseling rather than a one-size-fits-all approach. A patient who values spectacle independence may accept a higher risk of glare or halos, while a patient with demanding night-driving requirements may prefer a different optical strategy. The review also illustrates why patient-reported outcomes should sit alongside visual acuity when evaluating premium IOLs. In clinic, discussing benefits and trade-offs before surgery can be as important as the choice of IOL platform itself.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A Cochrane review of randomized trials comparing multifocal and monofocal intraocular lenses found that multifocal IOLs improve unaided near vision and increase the likelihood of spectacle independence. Distance visual acuity was broadly similar between lens strategies. The trade-off was a higher frequency of optical phenomena, particularly glare and halos, with the certainty of evidence varying across outcomes. The review is highly relevant to contemporary presbyopia-correcting cataract practice because the decision is not simply about maximizing an acuity number. Patient selection, expectations, ocular surface status, macular health, contrast sensitivity, and tolerance for night-vision phenomena all influence satisfaction. For surgeons, the evidence supports individualized lens counseling rather than a one-size-fits-all approach. A patient who values spectacle independence may accept a higher risk of glare or halos, while a patient with demanding night-driving requirements may prefer a different optical strategy. The review also illustrates why patient-reported outcomes should sit alongside visual acuity when evaluating premium IOLs. In clinic, discussing benefits and trade-offs before surgery can be as important as the choice of IOL platform itself.
last month
A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
5 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
6 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
6 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
6 days back
